Valuation DexCom, Inc. Boerse Muenchen
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time
Boerse Muenchen
23:43:59 16/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 76.23 EUR | +1.64% |
|
+5.74% | +33.32% |
| 09-16 | Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing | MT |
| 09-14 | DexCom Promotes CFO Jereme Sylvain to Additional COO Role | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 32,959 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 27.33% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 32,198 | 31,897 | 31,082 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 22.85% | -0.93% | -2.56% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 35x | 29.4x | 24.3x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.6x | 9.66x | 7.44x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.5x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.3x | 5.68x | 5.1x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.16x | 5.5x | 4.81x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19.3x | 16.6x | 14x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25.8x | 22x | 18.1x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 31.5x | 26.1x | 21.2x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.17% | 3.83% | 4.73% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,921 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,447 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 87.34 | 87.34 | 87.34 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29x | 4x | 15.48x | 2.51% | 177B | |
| 19.59x | 3.57x | 12.77x | 3.04% | 118B | |
| 17.44x | 0.2x | 12.75x | 0.75% | 60.78B | |
| 35.83x | 3.45x | 11.82x | 2.11% | 49.53B | |
| 27.35x | 6.71x | 17.3x | 1.46% | 48.29B | |
| 34.65x | 6.09x | 19.13x | -.--% | 32.96B | |
| 42.59x | 1.25x | 11.58x | 0.22% | 28.94B | |
| 42.22x | 7.4x | 26.55x | 0.25% | 25.48B | |
| 49.45x | 6.68x | 21.46x | 0.43% | 21.77B | |
| Average | 33.12x | 4.37x | 16.54x | 1.2% | 62.59B | |
| Weighted average by Cap. | 28.65x | 3.92x | 15.19x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
